Freedom Leaf Enters $20 Billion Anti-Cholesterol Market With Acquisition of a Patent Pending Non-Prescription Formula. No FDA Approval Required. Complimentary Diversification In Health Care
While This Formula is Not Hemp Extract-Based, it Fits Perfectly with Our Focus on Health & Wellness, Including Our Ayurvedic ...
